China 中国

监管审查:假冒产品、含量不符、 NMN 合法化

监管审查:假冒产品、含量不符、 NMN 合法化

By Hui Ling Dang

本期监管动态为您带来最新进展,包括马来西亚公司 Holista Colltech 因旗下 Omega-3 产品遭遇假冒问题呼吁行业加强与监管机构沟通、澳大利亚监管机构警示进口褪黑素补充剂含量不符问题、美国 FDA 宣布 NMN 可作为膳食补充剂合法使用。

聚焦日本:三得利、明治、大冢制药等

聚焦日本:三得利、明治、大冢制药等

By Hui Ling Dang

关注日本营养保健品企业及市场最新动向,包括三得利 CEO 因药物调查辞职事件引发的风波、明治的 NMN 胶原蛋白产品、大冢制药市场扩张等。

IPA opens China office, unveils upcoming plans

Vitafoods Asia 2025

IPA opens China office, unveils upcoming plans

By Tingmin Koe

The International Probiotics Association (IPA) has officially opened its China office located in Shanghai, and Executive Director George Paraskevakos recently spoke with NutraIngredients on the association’s plans in the country.

FDA declares NMN lawful in dietary supplements

FDA declares NMN lawful in dietary supplements

By Stephen Daniells

The U.S. Food and Drug Administration (FDA) has responded to a Citizen Petition from the Natural Products Association (NPA) and the Alliance for Natural Health USA (ANH) on the status of NMN, declaring the vitamin B3 form to be lawful for use in dietary...

聚焦日本:乐敦、麒麟、卡乐比等

聚焦日本:乐敦、麒麟、卡乐比等

By Hui Ling Dang

本期为您带来健康营养领域最新研究发现,包括益生菌降低饮酒后乙醛水平、生育三烯酚改善关节健康等前沿动态。

聚焦日本:森永乳业、Monteloeder、乐敦等

聚焦日本:森永乳业、Monteloeder、乐敦等

By Hui Ling Dang

了解日本营养保健品公司和市场的最新动态,包括森永乳业的新增长引擎、Monteloeder 对青少年健康产品品类的雄心、乐敦制药最新推出的补充剂等。

Boswellia effective for knee pain, stiffness — meta-analysis

Boswellia effective for knee pain, stiffness — meta-analysis

By Tingmin Koe

Boswellia appears to be more effective than other commonly used nutritional supplements for addressing knee pain and stiffness in people suffering from knee osteoarthritis, say findings of a new systematic review and meta-analysis.

Can supplements protect against UV-induced skin damage?

Can supplements protect against UV-induced skin damage?

By Asia Sherman

Within the booming anti-aging supplement market, beauty-from-within represents a fast-growing segment as consumers turn to ingestible collagen, hyaluronic acid, vitamins and antioxidants to fend off internal and external insults that degrade youthful...

BYHEALTH profits down 17%, looks to SEA for new growth

BYHEALTH profits down 17%, looks to SEA for new growth

By Tingmin Koe

China health supplements giant BYHEALTH has continued to see a decline in its sales and profits, and the company is pumping more resources to grow its international business, especially in South East Asia.

China sees growing interest from Italian nutra firms

Healthplex Expo 2025

China sees growing interest from Italian nutra firms

By Tingmin Koe

More Italian nutraceutical firms are seeing China as a potential export destination, with a group of companies forming the Italian pavilion for the first time at the Healthplex Expo 2025 (HNC Expo) held in China.

Supplier update: dsm-firmenich, PhytoGaia, TSI in the spotlight

Supplier update: dsm-firmenich, PhytoGaia, TSI in the spotlight

By Tingmin Koe

This round-up looks at the supplier firms driving new developments across Asia-Pacific’s nutraceuticals market, including dsm-firmenich and PhytoGaia’s research on cellular health, TSI’s premiere on Shanghai Stock Exchange and more.